Catheter Precision, Inc. (NYSE American:VTAK) today announced that at the recently held European Society of Cardiology (ESC) Symposium, interim results demonstrating the use of VIVO in localizing the ...
The RESILIENCE clinical trial has been designed to explore the effectiveness and safety of remote ischemic conditioning (RIC) ...
The REVIVED-BCIS2 trial failed to show that multivessel PCI improved event-free survival and LVEF among patients with severe ischemic cardiomyopathy. The primary outcome, all-cause mortality or ...
Increased mitochondrial Ca 2+ uptake has been implicated in the QT prolongation and lethal arrhythmias associated with nonischemic cardiomyopathy. We attempted to define the role of mitochondria in ...
This concerning trend comes alongside the already alarming increase in chronic diseases, rooted in what’s commonly known as ...
Medpage Today on MSN1d
Reconsider When a Prophylactic ICD Is Needed in Nonischemic Dilated CardiomyopathyBetter imaging parameters may exist for risk stratification in nonischemic dilated cardiomyopathy (NIDCM), based on a ...
CLV-100 is under clinical development by Cytopeutics and currently in Phase II for Graft Versus Host Disease (GVHD).
Keywords: Sudden cardiac death, risk stratification, early heart failure, ischemic cardiomyopathy, non-ischemic cardiomyopathy, non-invasive diagnostics, invasive procedures, device therapy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback